From: Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis
Paliperidone ER 6-12 mg/day n = 179 | Risperidone 2-4 mg/day n = 113 | Risperidone 4-6 mg/day n = 129 | Pooled Placebo n = 217 | |
---|---|---|---|---|
Age, years, mean (SD) | 37.4 (11.3) | 37.8 (10.6) | 37.1 (10.1) | 37.4 (10.4) |
Female, n (%) | 45 (25.1) | 31 (27.4) | 32 (24.8) | 41 (18.9) |
Race, n (%) | ||||
Caucasian | 136 (76.0) | 83 (73.5) | 99 (76.7) | 138 (63.6) |
Other | 43 (24.0) | 30 (26.5) | 30 (23.3) | 79 (36.4) |
BMI, mean (SD), kg/m2 | 25.2 (4.7) | 25.5 (3.3) | 25.5 (3.4) | 25.1 (4.2) |
PANSS total score, mean (SD) | 94.3 (11.9) | 94.4 (15.2) | 96.2 (16.6) | 93.4 (12.2) |
CGI-S score, mean (SD) | 4.8 (0.7) | 4.8 (0.6) | 4.8 (0.7) | 4.7 (0.8) |